glp-1 side effects cancer Glucagon-like peptide 1 receptor agonists and risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research SABCS 2025: Can GLP-1s Help
Description
Semaglutide is a close second with a longer safety track record
These data instill optimism about the impact that this drug might have in the treatment of T2DM and its complications in every day clinical practice
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are an emerging class of glucose-lowering drugs that are increasingly used in the treatment of type 2 diabetes (T2D) and obesity
Do not change, adjust, or discontinue any medications or prescribed treatments without your physician's guidance
However, theres a growing trend thats capturing attention both in clinical practice and popular culture: GLP-1 microdosing
